Wegovy Price Guide: The Factors That Drive Your Cost

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The five factors behind every Wegovy quote

Ask five people what Wegovy costs and you may hear five answers, because the figure is assembled from variables: insurance coverage, the FDA-approved indication on the prescription, manufacturer savings-card eligibility, pharmacy pricing, and whether a compounded alternative is available through a licensed pharmacy pathway. Understanding those levers explains the wide range readers see quoted, so let us take them one at a time.

Browse the full PlexusDx Education Hub library on GLP-1 therapies, weight protocols, and metabolic genetics.

List price is the starting line, not the finish

Wegovy list price is approximately $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. Treat that as the opening figure before insurance, rebates, savings cards, and pharmacy negotiation move it. What lands on your receipt depends on your plan, formulary, prior authorization, and the indication written on the script.

Coverage, prior authorization, and Medicare

Whether a commercial plan pays turns on the indication and the plan's own formulary and prior-authorization rules. Type 2 diabetes coverage for GLP-1 receptor agonists is common; chronic weight management coverage is more variable, frequently gated by BMI-based prior authorization, and sometimes excluded outright. Medicare, importantly, does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products.

Manufacturer cards and their fine print

Novo Nordisk's manufacturer savings card can substantially cut monthly cost for eligible commercially-insured patients, but the fine print matters: it typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and it carries monthly and annual caps. Terms change, so check the manufacturer site at fill time. Discount platforms like GoodRx and SingleCare publish separate coupon prices that move by pharmacy.

What compounding changed in 2024-2025

During the FDA-declared shortages of semaglutide and tirzepatide, 503A pharmacies legally compounded these molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without eliminating all legitimate activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified, priced separately, and are not identical to the brand products.

Three real out-of-pocket scenarios

Covered indication plus savings card

With commercial insurance that covers the indication and the savings card applied, eligible patients may pay as little as $25 per month, depending on plan terms and caps.

Uncovered indication

When commercial insurance does not cover the indication, cash cost sits closer to list price minus whatever coupon applies.

No insurance

Uninsured, cash-pay cost approaches list. Compounded protocols through PlexusDx Weight Management Protocols use a separate pricing structure published on each product page.

Reading your own metabolism first

Cost drivers explain the number; they do not explain how your body will engage the pathway. That part starts with your genetics.

Upstream of any GLP-1 decision, the PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, mapping variants such as FTO, GLP1R, and MC4R that shape your baseline appetite, satiety, and energy-balance biology. It never predicts how you will respond to a specific drug, and it is not a drug-response predictor; it simply gives you the metabolic backdrop to bring into a provider conversation. That is the test-before-you-invest sequence PlexusDx applies to every protocol: understand the biology first, then weigh the options with a clinician rather than guessing. To see the compounded protocols that pair with that context, explore the Weight Management Protocols collection, all delivered through licensed 503A compounding.

Why online quotes vary so widely

The spread of prices readers encounter online is not noise; it reflects genuinely different situations. One quote assumes covered insurance and a savings card, another assumes cash pay, and a third describes a compounded protocol from a licensed pharmacy. None is wrong, but none is universal. When you see a number, the productive response is to ask which scenario it describes and whether that scenario matches yours. Labeling each quote by its assumptions turns a confusing range into a map, and it keeps you from anchoring on a figure that was never going to apply to your coverage or indication in the first place.

Frequently Asked Questions

How much does Wegovy cost per month?

List price is roughly $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. Insurance, savings cards, and pharmacy pricing can move that figure substantially in either direction, so confirm your actual number with the pharmacy before you fill.

Does insurance cover Wegovy?

It depends on your plan, formulary, the FDA indication on the prescription, and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while chronic weight management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there coupons or savings cards for Wegovy?

Novo Nordisk publishes a manufacturer savings card for commercially-insured patients who meet eligibility criteria, and platforms like GoodRx publish separate discount prices. Government-insurance patients are typically excluded from the manufacturer card, so check the manufacturer site at fill time for current terms.

Are there lower-cost alternatives to Wegovy?

Licensed compounding pharmacies prepare compounded semaglutide and tirzepatide at price points separate from the brand. These are legally and factually different, not generics. PlexusDx offers both through its Weight Management Protocols, with per-protocol pricing published on each product page rather than a single headline rate.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.